IRC
RMD icon

Investors Research Corp’s ResMed RMD Stock Holding History

Investors Research Corp’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$5.93K – 1034
2024
Q2 		$5.93K Hold
31
– – ﹤0.01% 795
2024
Q1 		$6.14K Hold
31
– – ﹤0.01% 779
2023
Q4 		$5.33K Hold
31
– – ﹤0.01% 817
2023
Q3 		$4.58K Hold
31
– – ﹤0.01% 839
2023
Q2 		$6.77K Hold
31
– – ﹤0.01% 822
2023
Q1 		$6.79K Hold
31
– – ﹤0.01% 834
2022
Q4 		$6.45K Hold
31
– – ﹤0.01% 839
2022
Q3 		$7K Buy
31
+15
+94% +$3.41K ﹤0.01% 811
2022
Q2 		$3K Buy
+16
New +$3.41K ﹤0.01% 946

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Investors Research Corp's RMD Position: Q3 2024 in Review

Investors Research Corp sold out of ResMed (RMD) in Q3 2024, closing a stake of 31 shares — an estimated $5.93K sold.

Investors Research Corp first reported a position in RMD in Q2 2022 and held it in 9 quarters. The position peaked at $7K in Q3 2022. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Investors Research Corp reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Investors Research Corp sold 31 ResMed shares in Q3 2024, an estimated $5.93K.
  • Investors Research Corp first reported a position in ResMed in Q2 2022 and held it in 9 quarters.
  • Investors Research Corp's ResMed position peaked at $7K in Q3 2022.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Investors Research Corp's 13F filing for Q3 2024, filed 12 Nov 2024.